Codes / ICD10CM / D05.80

D05.80 Other specified type of carcinoma in situ of unspecified breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other specified type of carcinoma in situ of unspecified breast

Summary

Other specified type of carcinoma in situ of the breast refers to non-invasive abnormal cell growth that remains localized within the breast tissue. It is an early-stage breast condition where cancerous cells have not spread beyond their original site. This category includes specific subtypes of in situ carcinoma that are not classified under more common types like ductal or lobular carcinoma in situ.

Causes

The exact cause is not fully understood, but it involves genetic mutations that disrupt normal cell growth regulation. Hormonal influences and other cellular changes may contribute to the development of these localized abnormalities.

Risk Factors

  • Advancing age, particularly in post-menopausal individuals.
  • Family history of breast cancer.
  • Genetic predispositions, such as mutations in BRCA1 or BRCA2 genes.
  • Prior breast conditions, including atypical hyperplasia or previous in situ carcinomas.
  • Prolonged estrogen exposure.

Symptoms

  • Often asymptomatic and detected during routine screening.
  • May present as a small, localized lump or changes in breast texture in rare cases.
  • Nipple discharge is uncommon but possible.

Diagnosis

Diagnosis typically begins with mammography, which may reveal microcalcifications or tissue abnormalities. Further evaluation often includes a biopsy to examine tissue samples under a microscope for confirmation.

Treatment Options

  • Surgery: Lumpectomy or mastectomy depending on the extent and location of the carcinoma in situ.
  • Radiation therapy may follow surgery to eliminate any remaining abnormal cells.
  • Hormonal therapy might be considered if the carcinoma is hormone receptor-positive.

Prognosis and Follow-Up

Prognosis is generally favorable as the condition is non-invasive and localized. Regular follow-up with mammograms and clinical breast exams is recommended to monitor for recurrence or progression.

Complications

  • Potential for progression to invasive breast cancer if left untreated.
  • Surgical complications, such as infection or scarring, may occur.
  • Radiation therapy side effects, including skin irritation or fatigue, are possible.

Lifestyle & Prevention

  • Maintain a healthy weight and engage in regular physical activity.
  • Limit alcohol consumption.
  • Consider genetic counseling if there is a family history of breast cancer.
  • Follow recommended breast cancer screening guidelines.

When to Seek Professional Help

  • Notice any new breast lumps, changes in breast texture, or nipple discharge.
  • Experience persistent breast pain or skin changes, such as redness or dimpling.
  • Have a family history of breast cancer and want to discuss risk assessment.

Tips for Medical Coders

When coding D05.80, ensure the documentation specifies "other specified type" of carcinoma in situ and confirms the breast is unspecified. Verify that the diagnosis aligns with the clinical findings and that no more specific subtype (e.g., ductal or lobular) is documented, as this code is reserved for less common in situ carcinomas.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D05.80 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.